help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2004-2520
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
90/9/5386    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lemos, M. C.
Right arrow Articles by Thakker, R. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lemos, M. C.
Right arrow Articles by Thakker, R. V.
Related Collections
Right arrow Calcium and Bone Metabolism
The Journal of Clinical Endocrinology & Metabolism Vol. 90, No. 9 5386-5392
Copyright © 2005 by The Endocrine Society

A Novel EXT1 Splice Site Mutation in a Kindred with Hereditary Multiple Exostosis and Osteoporosis

Manuel C. Lemos, Peter Kotanko, Paul T. Christie, Brian Harding, Theodora Javor, Christine Smith, Richard Eastell and Rajesh V. Thakker

Academic Endocrine Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford Center for Diabetes, Endocrinology, and Metabolism, Churchill Hospital (M.C.L., P.T.C., B.H., R.V.T.), Headington, Oxford OX3 7LJ, United Kingdom; Krankenhaus der Barmherzigen Brüder, Department of Internal Medicine, Teaching Hospital Medical University Graz (P.K., T.J.), A-8020 Graz, Austria; and Bone Metabolism Group, Division of Clinical Sciences, University of Sheffield, Northern General Hospital (C.S., R.E.), Sheffield S5 7AU, United Kingdom

Address all correspondence and requests for reprints to: Dr. Rajesh V. Thakker, Academic Endocrine Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford Center for Diabetes, Endocrinology, and Metabolism, Churchill Hospital, Headington, Oxford OX3 7LJ, United Kingdom. E-mail: rajesh.thakker{at}ndm.ox.ac.uk.

Context: Hereditary multiple exostosis (HME) is an autosomal dominant disorder characterized by the development of benign cartilage-capped tumors at the juxta-epiphyseal regions of long bones. HME is usually caused by mutations of EXT1 or EXT2.

Objective: The objective of this study was to investigate a three-generation Austrian kindred with HME for EXT1 and EXT2 mutations and for abnormalities of bone mineral density (BMD).

Methods: DNA sequence and mRNA analyses were used to identify the mutation and its associated consequences. Serum biochemical and radiological investigations assessed bone metabolism and BMD.

Results: HME-affected members had a lower femoral neck BMD compared with nonaffected members (z-scores, –2.98 vs. –1.30; P = 0.011), and in those less than 30 yr of age, the lumbar spine BMD was also low (z-scores, –2.68 vs. –1.42; P = 0.005). However, they had normal mobility and normal serum concentrations of calcium, phosphate, alkaline phosphatase activity, creatinine, PTH, 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, osteocalcin, and ß-crosslaps. DNA sequence analysis of EXT1 revealed a heterozygous g->c transversion that altered the invariant ag dinucleotide of the intron 8 acceptor splice site. RT-PCR analysis using lymphoblastoid RNA showed that the mutation resulted in skipping of exon 9 with a premature termination at codon 599. DNA sequence abnormalities of the osteoprotegerin gene, which is in close proximity to the EXT1 gene, were not detected.

Conclusions: A novel heterozygous acceptor splice site mutation of EXT1 results in HME that is associated with a low peak bone mass, indicating a possible additional role for EXT1 in bone biology and in regulating BMD.




This article has been cited by other articles:


Home page
Hum Mol GenetHome page
A. Ali, P. T. Christie, I. V. Grigorieva, B. Harding, H. Van Esch, S. F. Ahmed, M. Bitner-Glindzicz, E. Blind, C. Bloch, P. Christin, et al.
Functional characterization of GATA3 mutations causing the hypoparathyroidism-deafness-renal (HDR) dysplasia syndrome: insight into mechanisms of DNA binding by the GATA3 transcription factor
Hum. Mol. Genet., February 1, 2007; 16(3): 265 - 275.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
H Shen, J-R Long, D-H Xiong, Y-F Guo, P Xiao, Y-Z Liu, L-J Zhao, Y-J Liu, H-Y Deng, J-L Li, et al.
A genomewide scan for quantitative trait loci underlying areal bone size variation in 451 Caucasian families
J. Med. Genet., November 1, 2006; 43(11): 873 - 880.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society